With people shedding up to 20% of their weight during clinical trials and the highest doses causing nearly a 29% reduction, experts are optimistic this drug could revolutionize obesity treatment for menopausal women
However, this tolerance doesn't last forever
Once weight loss stabilizes, the next question is often what to do about skin laxity, uneven fullness, or body shape changes that medication alone will not address
GLP-1 Safety: Known Risks and Rare Complications While GLP-1 medications are clinically proven to be safe, they carry specific risks that require professional oversight
Both groups were injected with semaglutide 0.25 mg for the first dose, and, as expected, the single dose PK parameters appeared similar for both groups